The Efficacy of Phytoestrogens and Selective Estrogen Receptor Modulators in Perimenopause-Related Depression

Trial Profile

The Efficacy of Phytoestrogens and Selective Estrogen Receptor Modulators in Perimenopause-Related Depression

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Sep 2016

At a glance

  • Drugs P 081 (Primary) ; Raloxifene (Primary) ; Estradiol
  • Indications Depressive disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Jun 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 09 May 2012 Planned end date changed from 1 Feb 2012 to 1 Feb 2014 as reported by ClinicalTrials.gov.
    • 14 Jul 2009 Planned end date added to 1 Feb 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top